About (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate
(1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate (PubChem CID 15947374) has the molecular formula C31H38F3N5O4
and a molecular weight of 601.67 g/mol. Its IUPAC name is (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate |
| PubChem CID | 15947374 |
| Molecular Formula | C31H38F3N5O4 |
| Molecular Weight | 601.67 g/mol |
| Exact Mass | 601.29 |
| IUPAC Name | (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate |
| SMILES | CC(=O)N1CCC(OC(=O)N2CCC(n3ncc(C(=O)N4CC[C@@H](c5ccccc5C(F)(F)F)C4)c3C3CC3)CC2)CC1 |
| InChI | InChI=1S/C31H38F3N5O4/c1-20(40)36-16-11-24(12-17-36)43-30(42)37-14-9-23(10-15-37)39-28(21-6-7-21)26(18-35-39)29(41)38-13-8-22(19-38)25-4-2-3-5-27(25)31(32,33)34/h2-5,18,21-24H,6-17,19H2,1H3/t22-/m1/s1 |
| InChIKey | KDWQZXWEHNVFIZ-JOCHJYFZSA-N |
| XLogP | 5.19 |
| TPSA | 87.98 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 601.67 |
| LogP ≤ 5 | 5.19 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate?
The IUPAC name of (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate (CID 15947374) is (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate.
What is the SMILES notation for (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate?
The canonical SMILES for (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate is CC(=O)N1CCC(OC(=O)N2CCC(n3ncc(C(=O)N4CC[C@@H](c5ccccc5C(F)(F)F)C4)c3C3CC3)CC2)CC1.
What is the InChIKey of (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate?
The InChIKey is KDWQZXWEHNVFIZ-JOCHJYFZSA-N. The full InChI is InChI=1S/C31H38F3N5O4/c1-20(40)36-16-11-24(12-17-36)43-30(42)37-14-9-23(10-15-37)39-28(21-6-7-21)26(18-35-39)29(41)38-13-8-22(19-38)25-4-2-3-5-27(25)31(32,33)34/h2-5,18,21-24H,6-17,19H2,1H3/t22-/m1/s1.
What are the key properties of (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate?
(1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate has a molecular weight of 601.67 g/mol, XLogP of 5.19, 5 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1-acetylpiperidin-4-yl) 4-[5-cyclopropyl-4-[(3S)-3-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carbonyl]pyrazol-1-yl]piperidine-1-carboxylate is sourced from PubChem (CID 15947374), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).